Companies: 11,258     total market cap: โ‚น14683.759 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
2B70.DE
#1301
ETF rank
โ‚น111.65 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น996.48
Share price
-0.33%
Change (1 day)
60.51%
Change (1 year)
๐Ÿงฌ Biotech ETFs
Categories

Market capitalization of iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70.DE)

Market cap: โ‚น111.65 Billion

As of September 2026 iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) has a market cap of โ‚น111.65 Billion. The market capitalization, commonly called market cap of this exchange traded fund calculated by multiplying the outstanding shares with the current share price.

Market cap history of iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) in 2026

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com